Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Heba Allam

Concepts (121)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Ovarian Neoplasms
2
2017
474
0.810
Why?
N-Acetylglucosaminyltransferases
2
2017
19
0.750
Why?
Neoplastic Stem Cells
2
2017
104
0.660
Why?
High-Throughput Nucleotide Sequencing
1
2020
206
0.650
Why?
Software
1
2020
297
0.610
Why?
Receptors, Notch
1
2017
27
0.600
Why?
Carcinoma
1
2017
154
0.550
Why?
Neoplasms
2
2021
1321
0.540
Why?
Neoplasm Proteins
1
2017
360
0.500
Why?
Membrane Glycoproteins
1
2014
270
0.460
Why?
Carcinoma, Hepatocellular
3
2013
203
0.400
Why?
Signal Transduction
2
2021
1751
0.400
Why?
Health Level Seven
1
2021
7
0.400
Why?
Ribosome Subunits, Small, Eukaryotic
1
2009
2
0.370
Why?
Genes, src
1
2009
4
0.370
Why?
Peptide Chain Initiation, Translational
1
2009
15
0.360
Why?
Eukaryotic Initiation Factor-2
1
2009
18
0.360
Why?
Image Processing, Computer-Assisted
1
2021
256
0.360
Why?
Electronic Health Records
1
2021
203
0.330
Why?
Cell Transformation, Neoplastic
1
2009
200
0.330
Why?
Clinical Trials as Topic
1
2021
490
0.320
Why?
Glycosylation
2
2017
112
0.280
Why?
Gender Identity
1
2015
26
0.270
Why?
Multiple Myeloma
4
2021
3049
0.270
Why?
Data Mining
1
2015
38
0.270
Why?
Hepacivirus
3
2013
127
0.260
Why?
Hepatitis, Autoimmune
1
2005
29
0.250
Why?
Autoantibodies
1
2005
135
0.240
Why?
Gene Expression Profiling
3
2021
1141
0.240
Why?
Hepatitis C, Chronic
1
2005
89
0.240
Why?
Social Media
1
2015
104
0.230
Why?
Mutation
2
2020
1504
0.230
Why?
Plasma Cells
2
2021
239
0.220
Why?
Algorithms
2
2021
697
0.210
Why?
Intracellular Signaling Peptides and Proteins
2
2013
151
0.210
Why?
Polycomb Repressive Complex 2
1
2021
50
0.200
Why?
Evolution, Molecular
1
2021
103
0.190
Why?
Lymphoma, Follicular
1
2020
30
0.180
Why?
Exosome Multienzyme Ribonuclease Complex
1
2020
14
0.180
Why?
Cell Cycle
1
2021
275
0.180
Why?
Gene Dosage
1
2020
92
0.180
Why?
Genome, Human
1
2020
131
0.180
Why?
Humans
13
2021
54304
0.170
Why?
Proto-Oncogene Proteins B-raf
1
2020
92
0.170
Why?
Genomics
1
2020
313
0.160
Why?
Tissue Banks
1
2017
8
0.160
Why?
Female
7
2020
28457
0.150
Why?
Mice, Inbred NOD
1
2017
99
0.150
Why?
Cell Line, Tumor
3
2017
1551
0.150
Why?
Ovary
1
2017
105
0.150
Why?
Neoplasm Recurrence, Local
1
2021
645
0.150
Why?
Tumor Burden
1
2017
141
0.150
Why?
Xenograft Model Antitumor Assays
1
2017
219
0.150
Why?
RNA Interference
1
2017
195
0.150
Why?
RNA, Small Interfering
2
2014
253
0.150
Why?
Neoplasm Invasiveness
1
2017
294
0.140
Why?
Protein Processing, Post-Translational
1
2017
183
0.140
Why?
Kaplan-Meier Estimate
1
2017
514
0.140
Why?
Glycomics
1
2014
9
0.130
Why?
Fatty Acids, Monounsaturated
1
2013
15
0.120
Why?
Microtubules
1
2013
57
0.120
Why?
Tandem Mass Spectrometry
1
2014
248
0.110
Why?
Chromatography, High Pressure Liquid
1
2014
377
0.110
Why?
Virus Replication
1
2013
143
0.110
Why?
Indoles
1
2013
289
0.100
Why?
RNA, Viral
1
2011
141
0.100
Why?
Breast Neoplasms
1
2020
1248
0.090
Why?
Cell-Free System
1
2009
16
0.090
Why?
RNA Caps
1
2009
10
0.090
Why?
5' Untranslated Regions
1
2009
33
0.090
Why?
Data Collection
1
2021
319
0.090
Why?
Positron-Emission Tomography
1
2021
323
0.090
Why?
HeLa Cells
1
2009
291
0.080
Why?
Neoplasm Metastasis
1
2009
252
0.080
Why?
Stress, Physiological
1
2009
194
0.080
Why?
Tomography, X-Ray Computed
1
2021
1222
0.070
Why?
Prognosis
2
2021
2126
0.060
Why?
Autoimmunity
1
2005
38
0.060
Why?
Viral Load
1
2005
86
0.060
Why?
Language
1
2015
137
0.060
Why?
Magnetic Resonance Imaging
1
2021
1616
0.060
Why?
Animals
2
2017
14402
0.060
Why?
Genotype
1
2005
600
0.060
Why?
Liver
2
2011
1226
0.060
Why?
Syndecan-1
1
2021
82
0.050
Why?
Transcriptional Activation
1
2021
134
0.050
Why?
Remission Induction
1
2021
222
0.050
Why?
Diagnosis, Differential
1
2005
1143
0.050
Why?
Recurrence
1
2021
692
0.040
Why?
DNA Mutational Analysis
1
2020
217
0.040
Why?
Male
3
2020
27335
0.040
Why?
Disease Progression
1
2021
915
0.040
Why?
Survival Rate
1
2020
954
0.040
Why?
Middle Aged
2
2020
13076
0.040
Why?
Cell Proliferation
1
2021
1097
0.040
Why?
Adult
2
2020
14189
0.040
Why?
Follow-Up Studies
1
2020
2389
0.030
Why?
Cell Cycle Checkpoints
1
2013
35
0.030
Why?
Antineoplastic Combined Chemotherapy Protocols
1
2020
1060
0.030
Why?
Adolescent
1
2005
6896
0.030
Why?
Risk Factors
1
2021
3934
0.030
Why?
Antiviral Agents
1
2013
188
0.030
Why?
Down-Regulation
1
2013
388
0.030
Why?
Hepatocytes
1
2013
214
0.030
Why?
Keratin-19
1
2011
2
0.030
Why?
Replicon
1
2011
7
0.030
Why?
Transplantation, Heterologous
1
2011
76
0.030
Why?
Cell Survival
1
2013
657
0.030
Why?
Immunoenzyme Techniques
1
2011
166
0.020
Why?
Mice, Nude
1
2011
284
0.020
Why?
Real-Time Polymerase Chain Reaction
1
2011
206
0.020
Why?
Mice, Inbred BALB C
1
2011
371
0.020
Why?
Hepatitis C
1
2011
94
0.020
Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2011
674
0.020
Why?
Oligonucleotide Array Sequence Analysis
1
2011
474
0.020
Why?
Flow Cytometry
1
2011
547
0.020
Why?
RNA, Messenger
1
2011
1203
0.020
Why?
Liver Neoplasms
1
2011
352
0.020
Why?
Aged
1
2020
10054
0.020
Why?
Antineoplastic Agents
1
2013
1300
0.020
Why?
Mice
1
2011
6428
0.010
Why?
Allam's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description